A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
NCT ID: NCT03642639
Last Updated: 2025-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
809 participants
INTERVENTIONAL
2018-08-23
2025-06-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coils
MICRUSFRAME and GALAXY coils
MICRUSFRAME and GALAXY coils
MICRUSFRAME and GALAXY Coils
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MICRUSFRAME and GALAXY coils
MICRUSFRAME and GALAXY Coils
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient has an intracranial saccular aneurysm, ruptured or unruptured, suitable for embolization with coils
3. Patient is able and willing to comply with protocol and follow-up requirements
Exclusion Criteria
2. More than one aneurysm requiring treatment during the course of study
3. Fusiform aneurysm
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cerenovus, Part of DePuy Synthes Products, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reade De Leacy
Role: PRINCIPAL_INVESTIGATOR
Mount Sinai Hospital, New York
Osama Zaidat
Role: PRINCIPAL_INVESTIGATOR
Mercy Health St. Vincent Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona
Tucson, Arizona, United States
Mercy San Juan Medical Center
Carmichael, California, United States
University of California Irvine
Orange, California, United States
University of Florida
Gainesville, Florida, United States
Baptist Medical Center
Jacksonville, Florida, United States
University of Miami
Miami, Florida, United States
Memorial Health University
Savannah, Georgia, United States
Rush University
Chicago, Illinois, United States
University of Illinois
Chicago, Illinois, United States
Javon Bea Hospital
Rockford, Illinois, United States
Norton Healthcare
Louisville, Kentucky, United States
Maine Medical Center
Scarborough, Maine, United States
University of Massachusetts
Worcester, Massachusetts, United States
St. Louis University
St Louis, Missouri, United States
University of Buffalo
Buffalo, New York, United States
Mount Sinai Hospital
New York, New York, United States
Stony Brook University
Stony Brook, New York, United States
Westchester Medical Center
Valhalla, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Mercy Health St. Vincent Medical Center
Toledo, Ohio, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Oregon Health and Science University
Portland, Oregon, United States
Geisinger Clinic
Danville, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Greenville Health System
Greenville, South Carolina, United States
Tennessee Interventional and Imaging Associates
Chattanooga, Tennessee, United States
University of Tennessee
Knoxville, Tennessee, United States
Texas Stroke Institute
Plano, Texas, United States
University of Utah
Salt Lake City, Utah, United States
University of Virginia
Charlottesville, Virginia, United States
Algemeen Ziekenhuis Groeninge
Kortrijk, , Belgium
Centre Hospitalier Universitaire d'Amiens Picardie
Amiens, , France
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, , France
Hopital Roger Salengro-Centre Hospitalier Universitaire de Lille
Lille, , France
Praticien Hospitalier Université de Lorraine
Nancy, , France
Centre Hospitalier Regional Universitaire de Tours
Tours, , France
Universitatsklinikum Schleswig Holstein
Lübeck, , Germany
Galilee Hospital Naharyia
Nahariya, , Israel
Ospedale Niguarda Ca' Granda
Milan, , Italy
Policlinico Tor Vergata
Roma, , Italy
Ospedale Cannizzaro
Sicily, , Italy
Aichi Medical University Hospital
Aichi, , Japan
Okayama University Hospital
Okayama, , Japan
National Hospital Organization Osaka National Hospital
Osaka, , Japan
Tominaga Hospital
Osaka, , Japan
Kohnan Hospital
Sendai, , Japan
Meihokai Yokohama Shin-Toshi Brain Orthopedic Hospital
Yokohama, , Japan
Centro Hospitalar de Vila Nova de Gaia
Porto, , Portugal
Hospital Universitari i Politecnic La Fe
Valencia, , Spain
Hopitaux Universitaires de Geneve
Geneva, , Switzerland
University Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CNV_2017_01
Identifier Type: -
Identifier Source: org_study_id